Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
about
Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.Glial biomarkers in human central nervous system disease.Clinical pharmacology, creating current and future success in drug development.Locked-in Syndrome and 18F-fluorodeoxyglucose-positron Emission Tomography/Computed Tomography: Observations from a Case of Basilar Artery Thrombosis.Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.
P2860
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@en
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@nl
type
label
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@en
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@nl
prefLabel
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@en
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.
@nl
P2860
P50
P356
P1476
Role of PET and SPECT in the study of amyotrophic lateral sclerosis
@en
P2093
Marco Pagani
Maria Consuelo Valentini
P2860
P304
P356
10.1155/2014/237437
P407
P5008
P577
2014-04-10T00:00:00Z